ANI Pharmaceuticals | ANIP - 営業経費





営業経費 変化する 日付
AbbVie USD 10.27B 1000K 2026-06
ANI Pharmaceuticals USD 597.21M 34.91M 2026-06
Aurora Cannabis CAD 48.04M 81.94M 2026-03
Canopy Growth CAD 98.72M 11.51M 2026-03
Eli Lilly USD 10.52B 496M 2026-06
Emergent BioSolutions USD 555.9M 242.7M 2023-06
Heron Therapeutics USD 40.55M 1.46M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Novartis USD 9.29B 507M 2026-03
Omeros USD 59.16M 20.13M 2024-06
Perrigo USD 290.5M 645.1M 2026-06
Sun Pharmaceuticals INR 117.43B 648.5M 2026-06
Teva Pharmaceutical Industries USD 3.92B 691M 2026-06